CN104474421A - 一种治疗小儿夜惊啼哭的中药制剂及其制备方法 - Google Patents
一种治疗小儿夜惊啼哭的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN104474421A CN104474421A CN201410669529.2A CN201410669529A CN104474421A CN 104474421 A CN104474421 A CN 104474421A CN 201410669529 A CN201410669529 A CN 201410669529A CN 104474421 A CN104474421 A CN 104474421A
- Authority
- CN
- China
- Prior art keywords
- parts
- children
- chinese medicine
- night
- fright
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 124
- 238000002360 preparation method Methods 0.000 title claims abstract description 61
- 206010011469 Crying Diseases 0.000 title claims abstract description 17
- 208000000224 Night Terrors Diseases 0.000 title abstract description 4
- 206010041010 Sleep terror Diseases 0.000 title abstract description 4
- 229940079593 drug Drugs 0.000 claims abstract description 54
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 33
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 33
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 210000000582 semen Anatomy 0.000 claims description 23
- 230000008901 benefit Effects 0.000 claims description 22
- 239000000706 filtrate Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 21
- 241000217407 Margaritifera Species 0.000 claims description 17
- 238000001914 filtration Methods 0.000 claims description 15
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- 210000003038 endothelium Anatomy 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 229920001353 Dextrin Polymers 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 8
- 235000019425 dextrin Nutrition 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 7
- 238000002347 injection Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- -1 preparation Substances 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 239000008298 dragée Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000012567 medical material Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 210000004185 liver Anatomy 0.000 abstract description 47
- 210000002216 heart Anatomy 0.000 abstract description 38
- 210000000952 spleen Anatomy 0.000 abstract description 38
- 230000000694 effects Effects 0.000 abstract description 32
- 210000004072 lung Anatomy 0.000 abstract description 24
- 210000001835 viscera Anatomy 0.000 abstract description 20
- 230000001914 calming effect Effects 0.000 abstract description 16
- 210000003734 kidney Anatomy 0.000 abstract description 16
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 15
- 208000026435 phlegm Diseases 0.000 abstract description 15
- 238000010792 warming Methods 0.000 abstract description 11
- 210000005036 nerve Anatomy 0.000 abstract description 10
- 238000005728 strengthening Methods 0.000 abstract description 10
- 208000001431 Psychomotor Agitation Diseases 0.000 abstract description 7
- 206010038743 Restlessness Diseases 0.000 abstract description 7
- 210000004556 brain Anatomy 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 7
- 230000001939 inductive effect Effects 0.000 abstract description 3
- 241000132012 Atractylodes Species 0.000 abstract description 2
- 241000287828 Gallus gallus Species 0.000 abstract description 2
- 241000146384 Glaux Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000572565 Alpinia oxyphylla Species 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000209140 Triticum Species 0.000 abstract 1
- 235000021307 Triticum Nutrition 0.000 abstract 1
- 241000157373 Uncaria rhynchophylla Species 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 36
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 34
- 210000004369 blood Anatomy 0.000 description 32
- 206010010904 Convulsion Diseases 0.000 description 30
- 201000010099 disease Diseases 0.000 description 30
- 230000007812 deficiency Effects 0.000 description 24
- 230000036461 convulsion Effects 0.000 description 22
- 230000001717 pathogenic effect Effects 0.000 description 22
- 210000002784 stomach Anatomy 0.000 description 18
- 230000007958 sleep Effects 0.000 description 16
- 208000008454 Hyperhidrosis Diseases 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 15
- 206010037660 Pyrexia Diseases 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 15
- 206010011224 Cough Diseases 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 14
- 244000052769 pathogen Species 0.000 description 14
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 14
- 230000035900 sweating Effects 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 238000000034 method Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 230000002936 tranquilizing effect Effects 0.000 description 12
- 241000700159 Rattus Species 0.000 description 10
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 10
- 206010022437 insomnia Diseases 0.000 description 10
- 230000037396 body weight Effects 0.000 description 9
- 239000003172 expectorant agent Substances 0.000 description 9
- 230000003419 expectorant effect Effects 0.000 description 9
- 210000000232 gallbladder Anatomy 0.000 description 9
- 206010010071 Coma Diseases 0.000 description 8
- 206010033557 Palpitations Diseases 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 241001279009 Strychnos toxifera Species 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 208000013403 hyperactivity Diseases 0.000 description 7
- 230000002269 spontaneous effect Effects 0.000 description 7
- 229960005453 strychnine Drugs 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 206010015037 epilepsy Diseases 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 230000004438 eyesight Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000027939 micturition Effects 0.000 description 6
- 230000002618 waking effect Effects 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 238000007667 floating Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000000630 rising effect Effects 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 208000036119 Frailty Diseases 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 206010044565 Tremor Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 239000011800 void material Substances 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010011878 Deafness Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010043458 Thirst Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001166 anti-perspirative effect Effects 0.000 description 3
- 239000003213 antiperspirant Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000037237 body shape Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 231100000895 deafness Toxicity 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 208000017574 dry cough Diseases 0.000 description 3
- 230000008921 facial expression Effects 0.000 description 3
- 239000007952 growth promoter Substances 0.000 description 3
- 208000016354 hearing loss disease Diseases 0.000 description 3
- 239000008929 jingui shenqi Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000011514 reflex Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 208000019116 sleep disease Diseases 0.000 description 3
- 230000003860 sleep quality Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- KCEIOBKDDQAYCM-UHFFFAOYSA-N 8-bromo-1-methyl-6-phenyl-4h-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine Chemical compound C12=CC(Br)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 KCEIOBKDDQAYCM-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000345998 Calamus manan Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 206010008531 Chills Diseases 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 240000004859 Gamochaeta purpurea Species 0.000 description 2
- 206010019799 Hepatitis viral Diseases 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000032140 Sleepiness Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000027326 copulation Effects 0.000 description 2
- 210000000806 cranial fontanelle Anatomy 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000009429 distress Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229960002275 pentobarbital sodium Drugs 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 235000012950 rattan cane Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 208000020685 sleep-wake disease Diseases 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 230000008925 spontaneous activity Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 201000001862 viral hepatitis Diseases 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- PCGVPMHGSJFFTI-ZEYGOCRCSA-N (4ar,5as,8ar,13as,15as,15br)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2h-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one;nitric acid Chemical compound O[N+]([O-])=O.O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 PCGVPMHGSJFFTI-ZEYGOCRCSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003084 Areflexia Diseases 0.000 description 1
- 244000141006 Armeniaca sibirica Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 235000006487 Euryale ferox Nutrition 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241001080798 Polygala tenuifolia Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 1
- 241000287181 Sturnus vulgaris Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 238000009933 burial Methods 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000004317 gizzard Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000008616 guibi-tang Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229940059935 strychnine nitrate Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗小儿夜惊啼哭的中药制剂,所述中药制剂的原料药为:龙眼肉10~20份,白术10~20份,茯神10~20份,石菖蒲10~20份,鸡内金10~20份,山茱萸10~20份,蝉蜕10~20份,珍珠母10~20份,远志10~20份,浮小麦10~20份,钩藤10~20份,益智仁10~20份,麦冬10~20份,白芍10~20份,酸枣仁10~20份,黄精10~20份,煅牡蛎10~20份,柴胡10~20份。小儿夜惊的发生与其自身脏腑薄弱的基础密切相关。一旦受惊,则心神不宁、肺魄不安、肝魂不稳,肾志扰动、胆寒怯弱、气逆为恐,导致惊惕不安,发为夜寐惊啼。本发明避免使用西药带来的副作用,采用纯中药制剂,诸药合用,阴阳调和,共奏平肝宁心、安神定志之功。能驱外邪,补五脏,温中健脾、化痰醒神,安神补脑。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物原料的医用配制品,特别涉及一种治疗小儿夜惊啼哭的中药制剂及其制备方法。
背景技术
夜惊约见于3%的儿童中,男略多于女,可发生在儿童的任何时期,但以5-7岁为多见。青春期以后少见。睡眠质量的好坏直接影响着孩子身体和大脑的发育。良好的作息习惯和睡眠卫生(包括睡觉时不要开着灯,室内空气流通,睡姿正确,睡前不要吃过多的东西,等等),能够促进大脑正常发育并得到充分的休息。
家长帮孩子放宽心。排除了生理和身体上的因素,父母们就要尽量避免那些可能引发夜惊症的事情发生,从客观上解除孩子心里的压力。同时,以讲故事、做游戏的方式,对孩子进行有针对性的心理疏导,让他们解除焦虑、放松身心,培养他坚强的意志,开朗的性格。在上床后,家人亲切地陪孩子说说话,或共同听一段轻松的音乐,也往往能让孩子心情愉快地入睡,这是避免夜惊的好方法。白天适度增加孩子的运动量,不仅可以增强体质,还能促进脑神经递质的平衡。而且孩子白天的活动多了、累了,晚上也容易睡得深,提高睡眠质量。
夜寐不安、惊啼叫扰的证侯称为夜惊,即小儿受惊后,人寐时啼哭不安,时哭时止,或寐后定时啼哭,甚则通宵达旦为主要特征的一种病证。患儿常于睡眠中突然尖叫、啼哭,神情极度恐惧,可伴有汗出、呼吸急促、心率加快等表现,需经摇晃几下才能唤醒;如果未能唤醒,一般在醒时对夜惊发作一事通常表现为没有记忆;如记忆被唤醒,则患者能记得惊恐的感觉,具体的梦境内容却很少能被记住。
然而,小儿不擅于表达,因此大多只明显表现为恐惧啼哭症状,故多数发生于睡眠状态下的啼哭证候,又称之为夜啼。古医籍对于夜啼的记载颇丰,除与今之夜惊相关的描述之外,也有对非受惊而起的夜间啼哭做出记载,如《颅囟经·病证》云:“初生小儿至夜啼者,是有瘀血腹痛,夜乘阴而痛,则啼。”夜惊多为受惊吓引起,突闻怪声,乍见异物等均可导致夜惊。古医籍关于小儿夜惊的记载多见于“客忤”范畴。“客”即“客邪”,广义的“客邪”泛指使小儿受到惊吓的所有病因,狭义的“客邪”特指前来做客的陌生人、相貌凶恶之人、行为粗鲁之人的“形”和“为”等,都能成为使小儿受到惊吓的病因;“忤”则是指令人不愿正视,甚至是宁可逃避而不愿见到的人、事、物。
夜惊病因:与小儿阴阳平衡不稳定的生理特点相关。阴阳是维系人体健康的基础,阴阳互根,相互为用,相互依存,独阳不存,孤阴不长。正如《素问·宝命全形论篇》云:“人生有形,不离阴阳。”人出生后存在自身的阴阳平衡,但是小儿的阴阳平衡是阳气始终占主导地位的阴阳平衡。《颅囟经·脉法》云:“凡孩子三岁以下呼为纯阳,元气未散。”小儿的阳气相对成人的“大阳”而言,尚处于十分稚嫩状态,年龄越小,则阳气就越稚嫩。“阴”相对“阳”来讲,始终处于从属地位,随阳气不断生发而不断补充,故阴相对阳而言,处于更加稚嫩和不足的状态。《医学衷中参西录》提出:“盖小儿虽为少阳之体,而少阳实为稚阳也。”《温病条辨·解儿难》云:“古称小儿纯阳,非盛阳之谓。”“小儿稚阳未充,稚阴未长也。”因此,小儿阴阳平衡是不稳定的阴阳平衡。小儿这种不稳定的阴阳平衡,一旦受到惊恐等客邪所伤,则极易导致阴阳平衡紊乱、不相顺接而发生夜惊。
再者与小儿脏腑嫩弱的生理特点相关《素问·宣明五气篇》云:“五脏所藏,心藏神,肺藏魄,肝藏魂,脾藏意,肾藏志。”又指出:“胃为气逆,为哕为恐。”《灵枢·逆顺肥瘦篇》有云:“婴儿者,其肉脆血少气弱。”《诸病源候论·养小儿候》亦云:“小儿脏腑之气软弱。”《小儿药证直诀·变蒸》云:“五脏六腑,成而未全全而未壮也。”《小儿药证直诀·原序》云:“其骨气未成,形声未正,悲啼喜笑,变态不常。”该书还记载,若惊惕由于“邪热乘心”,即心阳浮动,易致邪热与浮阳合犯心神,则治疗“当安心,安神丸主之”。无不体现小儿脏腑嫩弱的生理特点。小儿夜惊的发生与其自身脏腑薄弱的基础密切相关。一旦受惊,则心神不宁、肺魄不安、肝魂不稳,肾志扰动、胆寒怯弱、气逆为恐,导致惊惕不安,发为夜寐惊啼。因此,夜惊的发生,与心、肺、肝、脾、肾、胆、胃等脏腑密切相关。
睡卧而惊的表现尚与水湿有关,如《素问·汗热病论篇》日:“诸水病者,故不褥卧,卧则惊,惊则咳甚也。”《素问·痹论篇》也载:“肝痹者,夜卧则惊,多饮,数小便,上为引如怀。”因水湿为阴邪,加上夜亦属阴,阴邪在阴盛时易诱感而令人发病,表现便是于寐时脑中现令人惊恐之象,患者因而惊吓至醒。又因肺藏魂而主气司呼吸,并关乎水道通调与否,若惊扰魂魄,致肺气宣肃失司,如此引发的夜惊还可见伴有咳嗽等症状。
本病的治疗多采取五脏论治,同时要抓住神志不安的本质,祛外邪、化痰涎并补足五脏之虚,加以安定神志之法。外感风邪而内伤肺魄者,从肺论治以解表宣散加之宁神定魄之法;热邪侵心而神志不安者,从心论治以清心安神祛惊;湿热内伤肝胆而发为夜惊者,从肝论治以清利湿热、疏肝利胆;脾虚痰凝而神昏者,从脾论治以温中健脾、化痰醒神;素来胆气亏虚,平时就表现为内向而容易受到惊吓者,宜从胆论治,主要以温胆镇怯为原则,兼以安魂定惊之法。
发明内容
本发明所要解决的技术问题在于,对于小儿夜惊啼哭,目前国外治疗,西药多是中枢神经兴奋药,毒副作用较大,且疗效不稳定,停药后易复发。中医学认为,小儿夜惊的发生与其自身脏腑薄弱的基础密切相关。一旦受惊,则心神不宁、肺魄不安、肝魂不稳,肾志扰动、胆寒怯弱、气逆为恐,导致惊惕不安,发为夜寐惊啼。小儿身体正在生长发育,所以应避免使用西药带来的副作用,本发明以纯正中药配伍,没有任何毒副作用,可以长期使用,并且见效快,治愈后不易复发。
为解决上述技术问题,本发明提供一种治疗小儿夜惊啼哭的中药制剂,其所述中药制剂的原料药的重量份数可以为:龙眼肉10~20份,白术10~20份,茯神10~20份,石菖蒲10~20份,鸡内金10~20份,山茱萸10~20份,蝉蜕10~20份,珍珠母10~20份,远志10~20份,浮小麦10~20份,钩藤10~20份,益智仁10~20份,麦冬10~20份,白芍10~20份,酸枣仁10~20份,黄精10~20份,煅牡蛎10~20份,柴胡10~20份。
所述治疗小儿夜惊啼哭的中药制剂,其所述中药制剂的原料药的重量份数还可以为:龙眼肉10~15份,白术10~15份,茯神10~15份,石菖蒲10~15份,鸡内金10~15份,山茱萸10~15份,蝉蜕10~15份,珍珠母10~15份,远志10~15份,浮小麦10~20份,钩藤10~20份,益智仁10~20份,麦冬10~20份,白芍10~20份,酸枣仁10~20份,黄精10~20份,煅牡蛎10~20份,柴胡10~20份。
所述治疗小儿夜惊啼哭的中药制剂,其所述中药制剂的原料药的重量份数也可以为:龙眼肉10~20份,白术10~20份,茯神10~20份,石菖蒲10~20份,鸡内金10~20份,山茱萸10~20份,蝉蜕10~20份,珍珠母10~20份,远志10~20份,浮小麦10~15份,钩藤10~15份,益智仁10~15份,麦冬10~15份,白芍10~15份,酸枣仁10~15份,黄精10~15份,煅牡蛎10~15份,柴胡10~15份。
为解决上述技术问题,本发明还提供一种治疗小儿夜惊啼哭的中药制剂的制备方法,其所述中药制剂为冲剂,的制备步骤包括:
a、取原料药放入乙醇中浸泡12小时以上,热提取2次,成膏状,为组分1;
b、药渣加水提取2次,浓缩过滤为膏状,为组分2;
c、将上述两种膏状合并,浓缩成粉末加糊精或蜂蜜调和,制粒。
所述步骤a中,可以取原料药泡入10倍量乙醇中浸泡12小时以上,加热提取2次,每次1-2小时,去上清液,合并提取液,静置后去上清液,然后放入减压浓缩罐内,减压回收乙醇,浓缩至药液浓度为0.6g生药/mL,抽滤至滤液的相对密度为20℃时1.06的浸膏,成为组分成组分1。
所述步骤b中,可以将上述乙醇提取过的原料药的药渣加10倍量水,然后放入提取罐加热煮沸1小时,过滤,滤液备用;滤渣加水,第二次加热,煮沸45分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸半小时,过滤;将三次滤液合在一起,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状,成为组分2。
所述步骤c中,可以将组分1和组分2的浸膏合并,然后放入减压浓缩罐内,回收乙醇,浓缩至相对密度为1.20,温度至60℃-70℃的浸膏,然后加糊精或蜂蜜搅拌,装入制粒机中制成颗粒,使用时直接冲服。
为解决上述技术问题,本发明也提供一种治疗小儿夜惊啼哭的中药制剂的制备方法,所述制剂的剂型为口服液剂,制备方法包括:
将所述组份原料药去杂,粉碎成颗粒,加水浸泡12小时;将浸泡好的原料置多功能提取罐中加水煎煮二次;第一次加总药材10倍量的水,煎煮1.5~2小时,取煎液,滤过;第二次加总量7倍量的水,煎煮1~1.2小时,取两次煎液混合,滤过;将过滤的滤液置入双效真空浓缩器中浓缩。
上述步骤中,浓缩进一步包括:
将上述步骤过滤的滤液置入双效真空浓缩器中,开始浓缩,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含1g生药量,加糊精或蜂蜜调和;制成口服液装瓶。
所述治疗小儿夜惊啼哭的中药制剂,其所述中药制剂的剂型可以为:糖衣片剂、薄膜衣片剂、肠溶衣片剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、制剂、丸剂、散剂、丹剂、溶液剂或注射剂。
本发明有益技术效果在于:本发明能避免使用西药带来的副作用,采用纯中药制剂,诸药合用,阴阳调和,共奏平肝宁心、安神定志之功。能驱外邪,补五脏,温中健脾、化痰醒神,安神补脑。小儿夜惊的根本原因还是小儿脏腑嫩弱、阴阳失和小儿阴阳平衡是不稳定的阴阳平衡。小儿这种不稳定的阴阳平衡,一旦受到惊恐等客邪所伤,则极易导致阴阳平衡紊乱、不相顺接而发生夜惊。小儿夜惊的发生与其自身脏腑薄弱的基础密切相关。一旦受惊,则心神不宁、肺魄不安、肝魂不稳,肾志扰动、胆寒怯弱、气逆为恐,导致惊惕不安,发为夜寐惊啼。本发明采用纯中药制剂,能驱外邪,补五脏,温中健脾、化痰醒神,安神补脑。小儿身体正在生长发育,所以应避免使用西药带来的副作用,本发明以纯正中药配伍,没有任何毒副作用,可以长期使用,并且见效快,治愈后不易复发。
具体实施方式
小儿不论内因脏腑嫩弱、阴阳失和、水湿内停等所致心神魂魄易受惊吓,还是外因客忤而致惊啼,最终都是由于受惊之后,使得神志、魂魄不能安于脏腑,发为惊恐、啼哭,此乃机体欲寻求一个给邪气以出路的表现,倘若忽视了首次夜惊发作,容易为机体留下为外邪所引动而再次发作夜惊的伏邪,客忤乃诱因,诱外邪引动伏邪之因,根本原因还是小儿脏腑嫩弱、阴阳失和。
小儿发生夜惊的根本原因在于小儿易虚易实的病理特点,加上“体禀少阳”的特性,阳气虽常有余但却也最为稚嫩,阳气浮动在外,故心神易好动于表而不好潜藏;或因小儿脏腑娇嫩,神气未充,其心气不足,神志亦较成人怯弱,五志未定,智慧未充,故魂魄易惊。所以,无论是阳气有余,心神浮越于外,或是正气不足,魂魄失舍于内,都能导致夜惊的发生。《小儿推拿广意》说:“凡夜啼有四,有惊热、有心热、有寒疝、有误触神,而成夜啼。惊热者,为衣衾太浓,过于温暖,邪热攻心,心与小肠为表里,夜啼而遗溺者是也·误触神者,面色紫黑;气郁如怒,若有恐惧,睡中惊跳是也。”夜惊主要以祛风解表、温胆镇怯、宁心安神、清肝利胆等法治疗,病位主要在心、肺、肝、胆,并涉及神、魂、魄等,病性以虚实夹杂为主,虚者以温、镇为大法,实者以驱、解为首先。
由于客忤多指发生于6月以内的小儿,而小婴儿除了吃饭、大小便之外几乎就是在睡觉,因此,夜惊不单指夜寐而惊,凡睡觉时发生的惊啼都属于夜惊范畴,包括白天睡觉,故夜惊的发生不分昼夜,只不过因为都发生于人寐之后,所以以“夜”冠“惊”字,“夜”即指待入睡后至睡醒时的这段时间,“惊”则简要且全面概括了本病的发生原因、表现症状,以及提示了治疗大法应以镇惊安神、定魂守魄为主。夜惊的发生,常在于客忤,但引起客忤的根本原因,仍在于患者的自身条件,或者从心神人手,或从胆为中正之官,胆气的虚实与人之勇怯息息相关来讨论。因此伴随着夜惊的辨证虚实有所不同,众医家对夜惊的治疗亦有扶正补虚和祛邪消实等两大不同方向。凡邪实者,如热邪侵心、郁邪入肝、水湿及伏痰扰动脏腑等,皆可引起五脏神的不安进而造成情志波动,遂发为夜寐惊啼、哭闹叫扰;素秉体虚者,感受外来陌生气息时,因不了解而产生的恐惧害怕,便能导致患儿因胆虚而魂怯,或心虚而神乱,或肺虚而魄动,或脾虚而痰堵,则中气失于温煦,或魂神魄动乱等都能造成患儿情志的不安定,阳气充足之时,尚且能控制住这种不安分状态,待到阳人而阴静之时,便容易发为客忤惊啼;倘若遇外感风寒、湿热或内伏痰湿侵犯,加之小儿真元未聚,神志未充,便容易发为正虚邪盛、虚实夹杂证候,亦能导致神志昏乱而夜惊。
本病的治疗多采取五脏论治,同时要抓住神志不安的本质,祛外邪、化痰涎并补足五脏之虚,加以安定神志之法。外感风邪而内伤肺魄者,从肺论治以解表宣散加之宁神定魄之法;热邪侵心而神志不安者,从心论治以清心安神祛惊;湿热内伤肝胆而发为夜惊者,从肝论治以清利湿热、疏肝利胆;脾虚痰凝而神昏者,从脾论治以温中健脾、化痰醒神;素来胆气亏虚,平时就表现为内向而容易受到惊吓者,宜从胆论治,主要以温胆镇怯为原则,兼以安魂定惊之法。
方中龙眼肉辛甘化阳,龙眼肉合白芍调和阴阳,白芍收敛浮越阳气;酸枣仁、远志养心益阴、安神;珍珠母、牡蛎重镇安神,潜阳敛阴;柴胡清心泻火;茯苓清内热宁心安神;珍珠母镇惊定志:五味子滋阴益肾阴;蝉蜕善治小儿惊痫夜啼,钩藤能平肝熄风,两药俱为镇静安神定惊之佳品。诸药合用,阴阳调和,共奏平肝宁心、安神定志之功。
龙眼肉性味性温,味甜。补益心脾,养血安神。用于气血不足、心悸怔忡、健忘失眠、血虚萎黄。龙眼肉为无患子科植物龙眼的假种皮,又名益智、蜜脾、桂圆。龙眼肉是《中华人民共和国药典》的法定药物,理想的补品。中医认为,龙眼味甘、性温。入心、脾经。具有补益心脾、养血宁神、健脾止泻、利尿消肿等功效。适用于病后体虚、血虚萎黄、气血不足、神经衰弱、心悸怔忡、健忘失眠等病症。李时珍说:“龙眼大补”,“食品以荔枝为贵,而资益则龙眼为良。”《日用本草》:“益智宁心。”《得配本草》认为:龙眼“益脾胃,葆心血,润五脏,治怔忡。”《泉州本草》认为:龙眼“壮阳益气,补脾胃。”《药品化义》)曰:“桂圆,大补阴血,凡上部失血之后,入归脾汤同莲肉、芡实以补脾阴,使脾旺统血归经。如神思劳倦,心经血少,以此助生地、麦冬补养心血。又筋骨过劳,肝脏空虚,以此佐熟地、当归,滋肝补血。”至今,龙眼仍然是一味补血安神的重要药物。据现代研究,龙眼鲜食,味甜美爽口,且营养价值甚高,富含高碳水化合物、蛋白质、多种氨基酸和维生素B、C、钙、磷、铁、酒石酸、腺膘呤等,其中尤以含维生素P量多,对中老年人而言,有保护血管、防止血管硬化和脆性的作用。国外在研究龙眼时发现其含有一种活性成分有抗衰老的作用。这与我国最早的药学专著《神农本草经》中所言龙眼有轻身不老之说相吻合。故此有人认为龙眼是具有较好开发潜质的抗衰老食品。
茯神味甘、淡、性平,入药具有利水渗湿、益脾和胃、宁心安神之功用。性味甘、淡平。有渗湿、健脾、宁心等功能。用于痰饮、水肿、小便不利、泄泻、心悸、眩晕。茯苓皮,利水消肿,用于水湿浮肿等症,用于心虚惊悸,健忘,失眠,惊痫,小便不利。《别录》:疗风眩,风虚,五劳,口干。止惊悸,多恚怒,善忘。开心益智,养精神。
珍珠母是贝类珍珠层的粉末,具有平肝潜阳;安神定惊;清肝明目的功效。咸、寒。归肝、心经。平肝潜阳;安神定惊;清肝明目考证。功用主治平肝,潜阳,定惊,止血。治头眩,耳鸣,心悸,失眠,癫狂,惊痫,吐血,衄血,妇女血崩。《中国医学大辞典》:滋肝阴,清肝火。治癫狂惊痫,头眩,耳鸣,心跳,胸腹膜胀,妇女血热,血崩,小儿惊搐发痉。《饮片新参》:平肝潜阳,安神魂,定惊痫,消热痞、眼翳。
白术味苦、甘,温。归脾、胃经。主治健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。白术对瘤细胞有细胞毒作用,能降低瘤细胞的增殖率,减低瘤组织的侵袭性,提高机体抗肿瘤反应的能力。白术挥发油对小鼠艾氏腹水癌、淋巴肉瘤腹水型、食管癌(Ecal09)、肉瘤180等有抑制作用。白术内酯B腹腔注射对小鼠肉瘤民。也有显著抑制作用。《药性论》载其:君,味甘,辛,无毒。能主大风痹,多年气痢,心腹胀痛,破消宿食,开胃,去痰涎,除寒热,止下泄。主面光悦,驻颜,去黑。治水肿胀满,吐呕逆,腹内冷痛,吐泻不住,及胃气虚冷痢。
石菖蒲辛、苦,温。归心、胃经。主治化湿开胃,开窍豁痰,醒神益智。用于脘痞不饥,噤口下痢,神昏癫痫,健忘耳聋。理气,活血,散风,去湿。治癫痫,痰厥,热病神昏,健忘,气闭耳聋,心胸烦闷,胃痛,腹痛,风寒湿痹,痈疽肿毒,跌打损伤。《本经》:″主风寒湿痹,咳逆上气,开心孔,补五脏,通九窍,明耳目,出音声。″《别录》:″主耳聋,痈疮,温肠胃,止小便利,四肢湿痹,不得屈伸,小儿温疟,身积热不解,可作浴汤。聪耳目,益心智。″
鸡内金:鸡内金是指家鸡的砂囊内壁,系消化器官,用于研磨食物,该品为传统中药之一,用于消化不良、遗精盗汗等症,效果极佳,故而以“金”命名。甘,寒。归脾、胃、小肠、膀胱经。消食健胃助消化,涩精止遗。可以促进胃液分泌,提高胃酸度及消化力,使胃运动功能明显增强,胃排空加快。《日华子本草》:止泄精,并尿血、崩中、带下、肠风、泻痢。《滇南本草》:宽中健脾,消食磨胃。治小儿乳食结滞,肚大筋青,痞积疳积。
山茱萸,主治心下邪气寒热,温中,逐寒温痹,去三虫,久服轻身有强阴益精、安五脏、通九窍、止小便淋沥之功;久服明目、强力长年。山茱萸,又名山芋肉、药枣、实枣儿、枣皮、肉枣等,为我国常用名贵中药材,应用历史悠久。它以其补力平和、壮阳而不助火,滋阴而不腻膈,收敛而不留邪等特殊功效被历代医学所喜用。张仲景以山茱萸为君创制了“金匮肾气丸”。据化学分析,山茱萸含有生理活性较强的山茱萸甙、酒石酸、没食子酸、苹果酸、树酯、鞣质和多种维生素等有效成分,具有增强免疫、抗炎、抗菌等药理作用,是中医临床中常用的一味药。
远志(Radix Polygalae为常用中药,最早记载于《神农本草经》,列为上品,并被视为养命要药,来源于远志科植物远志Polygala tenuifoliaWilld.和卵叶远志P.sibirica L.的干燥根。性温,味苦、辛,具有安神益智、祛痰、消肿的功能,用于心肾不交引起的失眠多梦、健忘惊悸,神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。《神农本草经》:主咳逆伤中,补不足,除邪气,利九窍,益智慧,耳目聪明,不忘,强志倍力。
钩藤甘苦;微寒。清热平肝;熄风止痉。主治:小儿惊风;夜啼;热盛动风;子痫;肝阳眩晕;肝火头胀痛。钩藤剂或醇提物0.1g/kg腹腔注射,能抑制小鼠自发活动,维持3-4小时,并能对抗咖啡因所致动物自发活动增强,但即使剂量加大至2.5g/kg也不能增强戊巴比妥钠所致催眠作用,却能延迟大剂量戊巴比妥钠引起的动物死亡时间。剂量增至5-10g/kg,仍不能使动物翻正反射消失。钧藤钩和茎的煎剂1g/kg腹腔注射,能使大鼠大脑皮层兴奋性降低,冲动总合能力减弱,部分大鼠阳性条件反射受影响,使反射时间延长。而对分化抑制和非条件反射却无明显的影响。钧藤醇浸剂2g/kg皮下注射给药,对豚鼠的实验性癫闲病有防治作用,能制止癫闲发生,但停药3天又会复发。同时,还能防止豚鼠致癫闲区剪毛引起的暴殄。《别录》:主小儿寒热,惊痫。《药性论》:主小儿惊啼,瘲热壅。《日华子本草》:治客忤胎风。《纲目》:大人头旋目眩,平肝风,除心热,小儿内钓腹痛,发斑疹。
益智仁味辛;性温,温肾固精缩尿,温脾开胃摄痰,主治脾胃虚寒;呕吐;泄泻;腹中冷育;口多唾涎;肾虚遗尿;尿频;遗精;白浊,多唾液等症。益智仁含挥发油、益智仁酮、维生素B1、维生素B2、维生素C、维生素E及多种氨基酸、脂肪酸等。益智仁煎剂具有健胃、抗利尿、减少唾液分泌的作用。其水提取物有抑制腹水型肉瘤S180。细胞增长的作用。其水提取物和乙醇提取物有抑制回肠收缩的作用。此外,其甲醇提取物有增强左心房收缩力、抑制氯化钾引起的免主动脉收缩和抑制前列腺素合成酶的活性等作用。肾虚遗尿、尿频者益智仁、乌药各等份。研为细末,酒煎山药未为糊,制丸如梧桐子大。每服9克,用淡盐汤或米饮送下,每日3次。或用盐炒益智仁、盐炒补骨脂各60克。共研为细末,分作6包,每天早晨以米汤泡服1包(成人加倍),6日为1个疗程。
蝉蜕甘,寒。归肺、肝经。功能主治:散风除热,利咽,透疹,退翳,解痉。用于风热感冒,咽痛,音哑,麻疹不透,风疹瘙痒,目赤翳障,惊风抽搐,破伤风。对士的宁所致小鼠惊厥的影响:小鼠ip蝉蜕0.3ml/10g。15分钟后ip士的宁1.3mg/kg。观察给士的宁后1小时内小鼠死亡数;记录从给士的宁至死亡的时间;对产生惊厥的小鼠,观察从给士的宁至开始惊厥的时间,与对照组比较,结果见表1。蝉蜕能减少士的宁引起的惊厥死亡数,并能延长惊厥动物的存活期,延长士的宁所致惊厥的潜伏期。蝉蜕及其不同部位煎剂对硝酸士的宁所致的惊厥亦有明显的对抗作用。含生药2.4g/ml蝉蜕头足煎液、去头足蝉蜕煎液及连头足蝉蜕煎液的抗惊厥作用与生理盐水对照组比较,经X测定均为P<0.01,差异非常显着。三种蝉蜕煎液分别组间比较,经X测定均为P>0.05,无显着性差异。《别录》:″主小儿痫;灰服之主久痢。″《药性论》:″治小儿浑身壮热惊痫,兼能止渴。″
酸枣仁中国最早的一部药书《神农本草经》中记载:“补中益肝,坚筋骨,助阴气,皆酸枣仁之功也。″明代李时珍《本草纲目》中记载,枣仁“熟用疗胆虚不得眠,烦渴虚汗之症;生用疗胆热好眠,皆足厥阴少阳药也。功效养肝,宁心,安神,敛汗。治虚烦不眠,惊悸怔忡,烦渴,虚汗。《本经》:主心腹寒热,邪结气聚,四肢酸疼,湿痹。《别录》:主烦心不得眠,脐上下痛,血转久泄,虚汗烦渴,补中,益肝气,坚筋骨,助阴气,令人肥健。《药性论》:主筋骨风,炒末作汤服之。《本草拾遗》:睡多生使,不得睡炒熟。王好古:治胆虚不眠,寒也,炒服;治胆实多睡,热也,生用。《本草汇言》:敛气安神,荣筋养髓,和胃运脾。《本草再新》:平肝理气,润肺养阴,温中利湿,敛气止汗,益志定呵,聪耳明目。药理作用:.镇静、催眠作用:酸枣仁煎剂给大白鼠口服或腹腔注射均表现镇静及嗜眠,无论白天或黑夜,酸枣仁均能表现上述作用。小白鼠口服时的镇静指数为1.95,与巴比妥类药物表现协同作用,酸枣仁被连续使用6天后,动物睡眠会变浅,持续时间缩短,即产生耐受性,但停药1周后可消失。
白芍入肝、脾经,养血柔肝,缓中止痛,敛阴收汗。治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下,妇人血闭不通,消瘀血,能蚀脓,益女子血。《日华子本草》:治风、补劳,主女人一切病,并产前后诸疾,通月水,退热,除烦,益气,天行热疾,瘟瘴,惊狂,妇人血运,及肠风,泻血,痔瘘。发背,疮疥,头痛,明目,目赤努肉。赤色者多补气,白者治血。
浮小麦味甘;性凉。归经心经。功能主治除虚热;止汗。主止阴虚发热;盗汗;自汗。《本草蒙筌》:″敛虚汗。″《纲目》:″益气除热,止自汗盗汗,骨蒸虚热,妇人劳热。″《现代实用中药》:″补心,止烦,除热,敛汗,利小便。″
麦冬性味功能:甘、微苦、凉、滋阴生津、润肺止咳、清心除烦。主治热病伤津、心烦、口渴、咽干肺热、咳嗽、肺结核。配沙参,肺胃同治,具有清肺凉胃,养阴生津之良好效用,用于阴虚肺燥或热伤肺阴所致的干咳少痰,咽喉干燥等症。配五味子,酸甘化阴,守阴所以留阳,阳留汗自止。功能养阴敛汗,用治阴虚汗多,心悸,肺虚久咳,少痰或痰粘不爽等。
黄精:黄精以根茎入药。具有补气养阴,健脾,润肺,益肾功能。用于治疗脾胃虚弱,体倦乏力,口干食少,肺虚燥咳,精血不足,内热消渴等症。对于糖尿病很有疗效。黄精具有降血压,降血糖,降血脂,防止动脉粥样硬化,延缓衰老和抗菌等作用,黄精多糖具有免疫激活作用。用于阴虚肺燥,干咳少痰,及肺肾阴虚的劳嗽久咳等。用于脾胃虚弱。既补脾阴,又益脾气,用于肾虚精亏得头晕,腰膝酸软,须发早白及消渴等。黄精壮筋骨,益精髓,变白发;适宜用于肺阴不足所致的咳嗽痰少,干咳无痰,咳血等症。
煅牡蛎:牡蛎含80%~95%的碳酸钙、磷酸钙,《中国药典》1995年版对牡蛎的炮制规定为“取净牡蛎,照明煅法煅至酥脆”。煅牡蛎:收敛固涩除酸的作用强,治疗胃疼、胃酸等。:收敛固涩,制酸止痛,重镇安神,软坚散结。应用:滑脱诸证(自汗,盗汗,尿频,带下,崩漏,遗精等),胃痛泛酸,心神不安,失眠,肝阳上亢,头晕目眩等。加强敛汗固表的作用煅牡蛎可与黄芪,麻黄根,浮小麦相配伍。与防风,白术相配伍有固涩止汗,疏风解表的功效
柴胡清虚热中药,用于感冒发热、寒热往来、疟疾、肝郁气滞、胸肋胀痛、脱肛、子宫脱落、月经不调。归肝经、胆经。功能:疏散退热,升阳舒肝。主治:感冒发热、寒热往来、疟疾,肝郁气滞,胸肋胀痛,脱肛,子宫脱落,月经不调。治疗病毒性肝炎:柴胡注射液(每1ml含生药2g)10~20ml加入50%葡萄糖液静注或5%葡萄糖液250~500ml静滴,每日1次,10次为1疗程,治疗病毒性肝炎120例,其中急性病例97例,有效率为98.4%;慢性病例23例,有效率为100%,对改善症状、回缩肝脾、恢复肝功及乙肝抗原阴转率均有较好作用。
本发明具体实施方式
具体实施例1
本发明胶囊剂的制备:取龙眼肉1500g,白术1500g,茯神1500g,石菖蒲1500g,鸡内金1500g,山茱萸1500g,蝉蜕1500g,珍珠母1500g,远志1500g,浮小麦1500g,钩藤1500g,益智仁1500g,麦冬1500g,白芍1500g,酸枣仁1500g,黄精1500g,煅牡蛎1500g,柴胡1500g,取上述原料药加入5-10倍量的乙醇中浸泡12小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,静置备用,成为组分1。将上述乙醇提取过的原料药的药渣加10倍量水,加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述两种提取液合并,减压回收乙醇并浓缩至药液浓度为0.6g生药/mL,抽滤后,滤液的相对密度约为20℃时1.08;浓缩至相对密度为1.20,温度至60℃-70℃的浸膏,静置备用,成为组分2。将组分1和组分2的浸膏合并,然后放入减压浓缩罐内,减压浓缩至相对密度为1.20,然后取出,放入烘干机烘干成粉末,放入胶囊中,成胶囊剂。
具体实施例2
本发明冲剂的制备:
取龙眼肉1200g,白术1300g,茯神1200g,石菖蒲1300g,鸡内金1100g,山茱萸1200g,蝉蜕1100g,珍珠母1200g,远志1100g,浮小麦1200g,钩藤1300g,益智仁1200g,麦冬1100g,白芍1200g,酸枣仁1200g,黄精1200g,煅牡蛎1300g,柴胡1300g。取原料药泡入10倍量乙醇中浸泡12小时以上,加热提取2次,每次1-2小时,去上清液,合并提取液,静置后去上清液,然后放入减压浓缩罐内,减压回收乙醇,浓缩至药液浓度为0.6g生药/mL,抽滤至滤液的相对密度为20℃时1.06的浸膏,成为组分成组分1。将上述乙醇提取过的原料药的药渣加10倍量水,然后放入提取罐加热煮沸1小时,过滤,滤液备用;滤渣加水,第二次加热,煮沸45分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸半小时,过滤;将三次滤液合在一起,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状,成为组分2。将组分1和组分2的浸膏合并,然后放入减压浓缩罐内,回收乙醇,浓缩至相对密度为1.20,温度至60℃-70℃的浸膏,然后加糊精或蜂蜜搅拌,装入制粒机中制成颗粒,使用时直接冲服。
具体实施例3
本发明口服液剂的制备:
取龙眼肉1100g,白术1200g,茯神1000g,石菖蒲1300g,鸡内金1000g,山茱萸1200g,蝉蜕1100g,珍珠母1200g,远志1100g,浮小麦1200g,钩藤1000g,益智仁1200g,麦冬1200g,白芍1200g,酸枣仁1100g,黄精1200g,煅牡蛎1300g,柴胡1100g。将原料药的药放入10倍量乙醇中,浸泡12小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后放入减压浓缩罐内,减压回收乙醇,浓缩至药液浓度为0.6g生药/mL,抽滤至滤液的相对密度为20℃时1.06的浸膏,成为组分2。将组分1和组分2合并后置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含1g生药量;浓缩后的膏剂加糊精调和,紫外线消毒杀菌后装瓶。
药理学毒性试验
一、试验材料:
(一)实验动物:小鼠NIH,体重25-28g,雌雄各半;大鼠Wistar体重130-160g,雌雄各半,大鼠、小鼠的饲料由山东医学院动物实验中心提供。
(二)受试药物:
1、本发明药物:实施例2所制的丸剂,三批量等量混合物实验时用蒸馏水稀释应用。
2、阳性对照药物:金匮肾气丸,市售。
二、试验方法及结果:
(1)取体重25-28g的健康小鼠80只,雌、雄各半,按性别和体重分别分成四组,每组20只。1、2、3组服用本发明药物,剂量分别为8.6g生药/kg/d,6.4g生药/kg/d,4.2g生药/kg/d,第4组服用阳性对照药金匮肾气丸,剂量为6g生药/kg/d,连用15天。
试验结果:1、2、3组小鼠比4组小鼠性兴奋度明显增强,1、2、3组小鼠的交配次数比4组小鼠的交配次数平均每日增加3次。
试验结果表明本发明药物对中枢神经系统有明显的兴奋作用,所以本发明药物对于调节人体机能平衡、益气、补血、延缓衰老增强新陈代谢,精神疲惫,性机能减退都有治疗依据。
本发明动物急性毒性试验
一、试验材料
(一)动物小鼠NIH种雌雄各半,体重20-22g,由山东医学院动物实验室提供。
(二)受试药物:本发明所制的口服液,用蒸馏水稀释成混悬液。
二、试验方法及结果:
小鼠最大耐受量测定:取健康小鼠32只,雌雄各半,在24小时之内分三组,灌胃肠每次0.6ml/只,总重量1.8ml,相当于原生药4.0g,即100g生药/kg/d,相当于临床65公斤人的857倍。小鼠给药后按常规饲料12天未见动物死亡及未出、现毒性反应。因此证明,本发明药物无毒副作用,临床应用安全可靠。
本发明药物组合物的动物长期毒性试验
一、试验材料及方法
(一)受试药物:本发明实施例所制的片剂。
(二)实验动物,健康大鼠Wistar,体重100-130g,140只雌雄各半,按性别及体重随机分组,四组,每组35只。1、2、3组服用受试药物,剂量分别为9.6/kg/d,6.4/kg/d,3.2/kg/d。4组对照给相应体积量的蒸馏水、大鼠均灌胃肠给药,每组一次连用6个月,处死一半,余下1/2停药观察12天全部死亡。
二、测试指标
(一)一般状况包括体重、饮食、情绪、活动能量。
(二)血象检查:红细胞计数、白细胞计数、血小板计数、血象等,血红蛋白定量计数。
(三)生化检查、血清蛋白定量、胆固醇、血糖定量。
(四)病理组织检查:实验结果后取半数动物称重,断头处死,取血,同时解剖心、肝、肾、肺、脑、脾、胃肠、膀胱、肾上腺做病理组织检查。
三、试验结果:经大鼠长期毒性试验表明,用本发明大剂量灌肠六个月,对大鼠的生长、体重增加、对脑、肝、肾功能均无毒副作用。对大鼠的各组织器官、循环系统未发现损害改变,用药组与对照组比较无明显差异。说明本发明药物具有温补肾阳、益气、补血、增强新陈代谢等药效,无毒性。
药物与临床实验
1一般资料
20例均为门诊患儿,其中男性11例,女性9例;年龄1~12岁,其中1~5岁10例,6~9岁5例,10~12岁5例;病程5天~6个月。主要临床表现为患儿熟睡中突然惊醒,瞪目坐起,躁动不安,面部表情恐怖,似见异物状,有时叫喊。发作时神志迷糊,家长呼之不醒,清醒后对夜惊发作情况完全不知。发作次数不定,一般连续发作数日或数十日,或隔数日发作1次。部分患儿夜惊发作后入睡时,喉中有痰鸣音。全部病例均行脑电图检查均未见明显异常。
2、治疗方法
用本发明治疗。本发明方剂:龙眼肉12g,白术11g,茯神12g,石菖蒲14g,鸡内金12g,山茱萸12g,蝉蜕13g,珍珠母12g,远志11g,浮小麦13g,钩藤12g,益智仁11g,麦冬12g,白芍11g,酸枣仁13g,黄精12g,煅牡蛎13g,柴胡12g。每日1剂,水煎2次混合,分早、中、晚3次口服。本组最少服用10剂,最长60剂,平均30剂。
3、治疗结果
经治疗20例中,14例痊愈(夜惊症状消失,1年内不发作);4例有效(症状减轻,发作间隔时间延长):2例无效(治疗后症状、间隔时间无变化)。总有效率90%。
4、体会
小儿夜惊是儿科临床常见的睡眠疾病之一,因影响正常睡眠,使脑下垂体分泌的生长激素减少,食欲减退,从而会影响儿童的生长发育,故应积极防治。祖国医学认为,本病病位在心肝,阴血不足是导致心肝火旺,神魂不舍的根本原因。小儿“阳常有余”、“阴常不足”,其“有余”是相对的,而“不足”则是绝对的。心藏神,主神志,脏和则神安,心主火属阳,日属阳而夜属阴,至夜间阴盛阳衰,由于心火过亢,阴不能潜阳,热扰神明,故入夜惊悸不安。肝主疏泄而调情志,体阴而用阳。肝血不足,肝体失柔,疏泄失调,久则肝阴亏损,内生虚热,相火妄动,魂不守舍,可导致睡眠障碍。
方中龙眼肉辛甘化阳,龙眼肉合白芍调和阴阳,白芍收敛浮越阳气;酸枣仁、远志养心益阴、安神;珍珠母、牡蛎重镇安神,潜阳敛阴;柴胡清心泻火;茯苓清内热宁心安神;珍珠母镇惊定志:五味子滋阴益肾阴;蝉蜕善治小儿惊痫夜啼,钩藤能平肝熄风,两药俱为镇静安神定惊之佳品。诸药合用,阴阳调和,共奏平肝宁心、安神定志之功。
诚如尤在泾氏在《金匮要略心典》中所云:“病见于阴,甚必及阳,病见于阳,穷必归阴,以法救之者,养其阳以救阴之偏,则阴以平而阳不伤;补其阴以救阳之过,则阳以和而阴不敝,《内经》‘用阴和阳、用阳和阴’之道也”。
具体实施例1
黄某,女,5岁。2012年12月10日诊。患儿夜惊3月余。平素胆小,1月前因其父遭遇车祸,当时血流满面,患儿目睹后当晚即睡眠不安,后逐渐加剧,睡觉时经常哭喊,躁动不安,几乎每夜必发。2月前开始出现入睡后1小时左右突然坐起,面部表情恐怖、似见异物状,伴有心悸、全身汗出。今来我处就诊。诊断舌红、苔薄黄,脉细数。证属心肝火旺,阴血不足。治宜平肝宁心,安神定志。方用:龙眼肉12g,白术11g,茯神12g,石菖蒲14g,鸡内金12g,山茱萸12g,蝉蜕13g,珍珠母12g,远志11g,浮小麦13g,钩藤12g,益智仁11g,麦冬12g,白芍11g,酸枣仁13g,黄精12g,煅牡蛎13g,柴胡12g。每日1剂,水煎2次混合,分早、中、晚3次口服。连服10剂。12月21日复诊,诉服药后夜惊发作次数大减,入睡后己不再坐起,前方再进10剂后,诸症皆平,睡眠安稳,一直未复发。
具体实施例2
赵某,男,6岁,1年级学生,体格羸弱,平时胆小,性格孤独,易激怒。2012年11月就诊,家长述其在一个月前未完成作业,家长惩罚其在一个人小黑屋呆了一个小时,后来经常在睡眠无故惊醒,哭闹不止。面部表情恐怖、似见异物状,伴有心悸、全身汗。检查身体也无其他疾病。诊断舌红、苔薄黄,脉细数。证属心肝火旺,阴血不足,方药组成:龙眼肉12g,白术11g,茯神12g,石菖蒲14g,鸡内金12g,山茱萸12g,蝉蜕13g,珍珠母12g,远志11g,浮小麦13g,钩藤12g,益智仁11g,麦冬12g,白芍11g,酸枣仁13g,黄精12g,煅牡蛎13g,柴胡12g。每日1剂,水煎2次混合,分早、中、晚3次口服。连服10剂。来复诊时家长说睡眠质量好很多,无故惊醒次数减少,但还是有夜惊现象。遂再进10剂。结果诸症皆平,睡眠安稳,一直未复发。
Claims (10)
1.一种治疗小儿夜惊啼哭的中药制剂,其特征在于,所述中药制剂的原料药的重量份数包括:龙眼肉10~20份,白术10~20份,茯神10~20份,石菖蒲10~20份,鸡内金10~20份,山茱萸10~20份,蝉蜕10~20份,珍珠母10~20份,远志10~20份,浮小麦10~20份,钩藤10~20份,益智仁10~20份,麦冬10~20份,白芍10~20份,酸枣仁10~20份,黄精10~20份,煅牡蛎10~20份,柴胡10~20份。
2.根据权利要求1所述治疗小儿夜惊啼哭的中药制剂,其特征在于,所述中药制剂的原料药的重量份数包括:龙眼肉10~15份,白术10~15份,茯神10~15份,石菖蒲10~15份,鸡内金10~15份,山茱萸10~15份,蝉蜕10~15份,珍珠母10~15份,远志10~15份,浮小麦10~20份,钩藤10~20份,益智仁10~20份,麦冬10~20份,白芍10~20份,酸枣仁10~20份,黄精10~20份,煅牡蛎10~20份,柴胡10~20份。
3.根据权利要求1所述治疗小儿夜惊啼哭的中药制剂,其特征在于,所述中药制剂的原料药的重量份数包括:龙眼肉10~20份,白术10~20份,茯神10~20份,石菖蒲10~20份,鸡内金10~20份,山茱萸10~20份,蝉蜕10~20份,珍珠母10~20份,远志10~20份,浮小麦10~15份,钩藤10~15份,益智仁10~15份,麦冬10~15份,白芍10~15份,酸枣仁10~15份,黄精10~15份,煅牡蛎10~15份,柴胡10~15份。
4.一种如权利要求1~3中任一项所述治疗小儿夜惊啼哭的中药制剂的制备方法,其特征在于,所述中药制剂的剂型为冲剂,其制备步骤包括:
a、取原料药放入乙醇中浸泡12小时以上,热提取2次,成膏状,为组分1;
b、药渣加水提取2次,浓缩过滤为膏状,为组分2;
c、将上述两种膏状合并,浓缩成粉末加糊精或蜂蜜调和,制粒。
5.根据权利要求4所述治疗小儿夜惊啼哭的中药制剂的制备方法,其特征在于,所述步骤a中,取原料药泡入10倍量乙醇中浸泡12小时以上,加热提取2次,每次1-2小时,去上清液,合并提取液,静置后去上清液,然后放入减压浓缩罐内,减压回收乙醇,浓缩至药液浓度为0.6g生药/mL,抽滤至滤液的相对密度为20℃时1.06的浸膏,成为组分成组分1。
6.根据权利要求4所述治疗小儿夜惊啼哭的中药制剂的制备方法,其特征在于,所述步骤b中,将上述乙醇提取过的原料药的药渣加10倍量水,然后放入提取罐加热煮沸1小时,过滤,滤液备用;滤渣加水,第二次加热,煮沸45分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸半小时,过滤;将三次滤液合在一起,用纱布过滤,残渣中加入50-60%乙醇,60℃-70℃继续浸提2h,每10min搅拌一次,纱布过滤,合并浸提液,浓缩成糊状,成为组分2。
7.根据权利要求4所述治疗小儿夜惊啼哭的中药制剂的制备方法,其特征在于,所述步骤c中,将组分1和组分2的浸膏合并,然后放入减压浓缩罐内,回收乙醇,浓缩至相对密度为1.20,温度至60℃-70℃的浸膏,然后加糊精或蜂蜜搅拌,装入制粒机中制成颗粒,使用时直接冲服。
8.一种如权利要求1~3中任一项所述治疗小儿夜惊啼哭的中药制剂的制备方法,其特征在于,所述制剂的剂型为口服液剂,制备方法包括:
将所述组份原料药去杂,粉碎成颗粒,加水浸泡12小时;将浸泡好的原料置多功能提取罐中加水煎煮二次;第一次加总药材10倍量的水,煎煮1.5~2小时,取煎液,滤过;第二次加总量7倍量的水,煎煮1~1.2小时,取两次煎液混合,滤过;将过滤的滤液置入双效真空浓缩器中浓缩。
9.根据权利要求8中任一项所述治疗小儿夜惊啼哭的中药制剂的制备方法,其特征在于,上述步骤中,浓缩进一步包括:
将上述步骤过滤的滤液置入双效真空浓缩器中,开始浓缩,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含1g生药量,加糊精或蜂蜜调和;制成口服液装瓶。
10.根据权利要求1~9任一项所述治疗小儿夜惊啼哭的中药制剂,其特征在于,所述中药制剂的剂型为:糖衣片剂、薄膜衣片剂、肠溶衣片剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、制剂、丸剂、散剂、丹剂、溶液剂或注射剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410669529.2A CN104474421A (zh) | 2014-11-20 | 2014-11-20 | 一种治疗小儿夜惊啼哭的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410669529.2A CN104474421A (zh) | 2014-11-20 | 2014-11-20 | 一种治疗小儿夜惊啼哭的中药制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104474421A true CN104474421A (zh) | 2015-04-01 |
Family
ID=52749122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410669529.2A Pending CN104474421A (zh) | 2014-11-20 | 2014-11-20 | 一种治疗小儿夜惊啼哭的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104474421A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104800771A (zh) * | 2015-05-15 | 2015-07-29 | 李守春 | 一种用于儿童夜惊症的中药制剂及其制备方法 |
CN118680973A (zh) * | 2024-08-26 | 2024-09-24 | 华龙圣爱中医集团有限公司 | 一种治疗小儿夜惊症的药物组合物及其制剂和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130045779A (ko) * | 2011-10-26 | 2013-05-06 | 고려대학교 산학협력단 | 미성숙 항체, 이를 이용한 연속 검출장치 및 실시간 연속 검출 방법 |
CN103830554A (zh) * | 2014-03-07 | 2014-06-04 | 朱克兰 | 一种治疗小儿夜啼的中药组合物及其制备方法 |
-
2014
- 2014-11-20 CN CN201410669529.2A patent/CN104474421A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130045779A (ko) * | 2011-10-26 | 2013-05-06 | 고려대학교 산학협력단 | 미성숙 항체, 이를 이용한 연속 검출장치 및 실시간 연속 검출 방법 |
CN103830554A (zh) * | 2014-03-07 | 2014-06-04 | 朱克兰 | 一种治疗小儿夜啼的中药组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
牛文贵: "桂枝加龙骨牡蛎汤合甘麦大枣汤治疗儿童夜惊20例", 《光明中医》 * |
王印: "《家庭医生现用现查》", 31 March 2002, 中医古籍出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104800771A (zh) * | 2015-05-15 | 2015-07-29 | 李守春 | 一种用于儿童夜惊症的中药制剂及其制备方法 |
CN104800771B (zh) * | 2015-05-15 | 2018-08-21 | 李守春 | 一种用于儿童夜惊症的中药制剂及其制备方法 |
CN118680973A (zh) * | 2024-08-26 | 2024-09-24 | 华龙圣爱中医集团有限公司 | 一种治疗小儿夜惊症的药物组合物及其制剂和应用 |
CN118680973B (zh) * | 2024-08-26 | 2024-10-25 | 华龙圣爱中医集团有限公司 | 一种治疗小儿夜惊症的药物组合物及其制剂和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048933B (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
CN102335330B (zh) | 一种治疗失眠的中药组合物 | |
CN104398986A (zh) | 一种安神补脑的淫羊藿口服液及其制备方法 | |
CN104256632A (zh) | 一种改善睡眠的保健品 | |
CN102784319B (zh) | 一种治疗气阴两虚型失眠的中药制备方法 | |
CN102772704A (zh) | 老年病药物 | |
CN101417093B (zh) | 一种治疗眩晕症的中药制剂 | |
CN104274754A (zh) | 一种治疗小儿遗尿的中药组合物及其制备方法 | |
CN104189819B (zh) | 一种用于调理情绪健康的中药制剂 | |
CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN104474421A (zh) | 一种治疗小儿夜惊啼哭的中药制剂及其制备方法 | |
CN101745042B (zh) | 一种具有解酒保肝作用的组合物及其制备方法 | |
CN104324329A (zh) | 一种安神补脑的桑葚口服液及其制备方法 | |
CN104524464A (zh) | 一种治疗多动症的中药制剂及其制备方法 | |
CN104208285A (zh) | 一种用于女性保健和延缓记忆力减退的中药制剂 | |
CN104397282A (zh) | 一种安神补脑的刺五加保健茶及其制备方法 | |
CN108041397A (zh) | 一种提升睡眠质量的固体饮料 | |
CN107158243A (zh) | 一种治疗慢性咽炎的中药配方 | |
CN104906485A (zh) | 儿童制剂 | |
CN105535587A (zh) | 一种治疗心肾不交型心悸失眠的中药制剂及其制备方法 | |
CN104274755A (zh) | 一种治疗小儿遗尿的中药制剂及其制备方法 | |
CN105831751A (zh) | 补气健脑的中药保健组合物、制备方法及其使用方法 | |
CN104547642A (zh) | 一种治疗女性纤维肌痛综合征的中药组合物 | |
CN105012732B (zh) | 一种用于治疗睡眠障碍综合征的中药丸剂及制备方法 | |
CN104840794B (zh) | 一种治疗老年性失眠的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150401 |